These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12424621)

  • 1. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease.
    Vijgen L; Van Gysel M; Rector A; Thoelen I; Esters N; Ceelen T; Vangoidsenhoven E; Vermeire S; Rutgeerts P; Van Ranst M
    Genes Immun; 2002 Nov; 3(7):400-6. PubMed ID: 12424621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
    Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
    Figueroa C; Peralta A; Herrera L; Castro P; Gutiérrez A; Valenzuela J; Aguillón JC; Quera R; Hermoso MA
    Eur Cytokine Netw; 2006 Jun; 17(2):125-30. PubMed ID: 16840031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of IBD5 locus to clinical features of IBD patients.
    Latiano A; Palmieri O; Valvano RM; D'Incà R; Vecchi M; Ferraris A; Sturniolo GC; Spina L; Lombardi G; Dallapiccola B; Andriulli A; Devoto M; Annese V
    Am J Gastroenterol; 2006 Feb; 101(2):318-25. PubMed ID: 16454837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.
    Celik Y; Dagli U; Kiliç MY; Törüner M; Ozen SC; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
    Scand J Gastroenterol; 2006 May; 41(5):559-65. PubMed ID: 16638698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population.
    Marrakchi R; Moussa A; Ouerhani S; Bougatef K; Bouhaha R; Messai Y; Rouissi K; Khadimallah I; Khodjet-el-Khil H; Najar T; Benammar-Elgaaeid A
    Inflamm Res; 2009 Mar; 58(3):155-60. PubMed ID: 19184348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of genotype-phenotype relationships and stratification by the CARD15 variant genotype for inflammatory bowel disease susceptibility loci using multiple short tandem repeat genetic markers.
    Crawford NP; Colliver DW; Funke AA; Young MN; Kelley S; Cobbs GA; Petras RE; Galandiuk S
    Hum Mutat; 2005 Feb; 25(2):156-66. PubMed ID: 15643611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymorphism of the IL1RN gene in Spanish patients with ulcerative colitis].
    González Sarmiento R; Araoz P; Rodríguez R; Oliveira A; Feranández Blanco I; Sánchez Rodríguez A
    Med Clin (Barc); 1999 Jun; 112(20):778-9. PubMed ID: 10422059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
    Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
    Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population.
    Zhou Z; Lin XY; Akolkar PN; Gulwani-Akolkar B; Levine J; Katz S; Silver J
    Am J Gastroenterol; 2002 Dec; 97(12):3095-101. PubMed ID: 12492195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
    Bid HK; Manchanda PK; Mittal RD
    Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.
    Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK
    J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of IL-13 gene +2044G/A mutation in patients with inflammatory bowel disease].
    Waterman M; Karban A; Nesher S; Weiss B; Shamir R; Eliakim R
    Harefuah; 2006 Nov; 145(11):789-92, 864. PubMed ID: 17183946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The distribution of gene polymorphisms in the intron 2 and exon 2 of interleukin-1 receptor antagonist and their correlation with the serum lipoprotein level].
    Xu P; Li Y; Zhang PA; Li XY; Li GS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):522-6. PubMed ID: 15231136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients].
    Ma P; Chen D; Pan J; Du B
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1237-41. PubMed ID: 12425801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.